Efficacy and Safety of Selinexor in Recurrent Glioblastoma

被引：0
|
作者：
Lassman, A. B. [1 ]
Wen, P. Y. [2 ]
van den Bent, M. [3 ]
Plotkin, S. R. [4 ]
Walenkamp, A. [5 ]
Green, A. [2 ,6 ]
Huang, X. [7 ]
Rodriguez-Lopez, K. Karla [7 ]
Kauffman, M. G. [7 ]
Shacham, S. [7 ]
Mau-Soerensen, M. [8 ]
机构：
[1] Columbia Univ, Irving Med Ctr, New York, NY USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Erasmus MC Canc Ctr, Rotterdam, Netherlands
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Univ Groningen, Groningen, Netherlands
[6] Univ Colorado, Ctr Canc, Aurora, CO USA
[7] Karyopharm Therapeut Inc, Newton, MA USA
[8] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
来源：
NEUROTHERAPEUTICS | 2020年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
12
引用
收藏
页码：1315 / 1316
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia
    Chen, Christine
    Siegel, David
    Gutierrez, Martin
    Jacoby, Meagan
    Hofmeister, Craig C.
    Gabrail, Nashat
    Baz, Rachid
    Mau-Sorensen, Morten
    Berdeja, Jesus G.
    Savona, Michael
    Savoie, Lynn
    Trudel, Suzanne
    Areethamsirikul, Nuchanan
    Unger, T. J.
    Rashal, Tami
    Hanke, Tim
    Kauffman, Michael
    Shacham, Sharon
    Reece, Donna
    BLOOD, 2018, 131 (08) : 855 - 863
  • [32] Efficacy and Safety of Selinexor for Heavily Pretreated Multiple Myeloma Treatment - A Systematic Review
    Tariq, Muhammad Junaid
    Farooqui, Arafat
    Faisal, Muhammad Salman
    Farooqi, Muhammad
    Shaukat, Tanveer
    Anjum, Ahmad
    Rehman, Saifur
    Ullah, Muhammad Qudrat
    Bajwa, Hamza
    Anwer, Faiz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E121 - E121
  • [33] Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis
    Hughes, David M.
    DeMari, Shayna
    Hassan, Hamza
    Sanchorawala, Vaishali
    Sloan, J. Mark
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (05): : E460 - E463
  • [34] EFFICACY AND SAFETY STUDY OF NEOADJUVANT EFINEPTAKIN ALFA (NT-I7) AND PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA
    Webb, Mason
    Sener, Ugur
    Burns, Terry
    Twohy, Erin
    Kizilbash, Sani H.
    Ruff, Michael
    Uhm, Joon
    Galanis, Evanthia
    D'Andre, Stacy
    Riviere-Cazaux, Cecile
    Lee, Byung Ha
    Flickinger, Lynn
    Parney, Ian
    Campian, Jian
    NEURO-ONCOLOGY, 2023, 25
  • [35] Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
    Leszek Królicki
    Frank Bruchertseifer
    Jolanta Kunikowska
    Henryk Koziara
    Bartosz Królicki
    Maciej Jakuciński
    Dariusz Pawlak
    Christos Apostolidis
    Saed Mirzadeh
    Rafał Rola
    Adrian Merlo
    Alfred Morgenstern
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 614 - 622
  • [36] Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
    Krolicki, Leszek
    Bruchertseifer, Frank
    Kunikowska, Jolanta
    Koziara, Henryk
    Krolicki, Bartosz
    Jakucinski, Maciej
    Pawlak, Dariusz
    Apostolidis, Christos
    Mirzadeh, Saed
    Rola, Rafal
    Merlo, Adrian
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 614 - 622
  • [37] Efficacy and safety study of neoadjuvant efineptakin alfa (NT-I7) and pembrolizumab in recurrent glioblastoma
    Webb, Mason
    Burns, Terry C.
    Twohy, Erin
    Sener, Ugur
    Kizilbash, Sani Haider
    Ruff, Michael W.
    Uhm, Joon H.
    Galanis, Evanthia
    D'Andre, Stacy D.
    Riviere-Cazaux, Cecile
    Lee, Byung Ha
    Flickinger, Lynn M.
    Parney, Ian F.
    Campian, Jian Li
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Efficacy and safety of tumor-treating fields in recurrent glioblastoma: a systematic review and meta-analysis
    Xiaohui Li
    Zetian Jia
    Yaqi Yan
    Acta Neurochirurgica, 2022, 164 : 1985 - 1993
  • [39] Retrospective Study of the Safety and Efficacy of Anlotinib Combined With Dose-Dense Temozolomide in Patients With Recurrent Glioblastoma
    She, Lei
    Su, Lin
    Shen, Liangfang
    Liu, Chao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Efficacy and safety of tumor-treating fields in recurrent glioblastoma: a systematic review and meta-analysis
    Li, Xiaohui
    Jia, Zetian
    Yan, Yaqi
    ACTA NEUROCHIRURGICA, 2022, 164 (08) : 1985 - 1993
12345